Company: SHPH
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001641172-25-001889
Chunk: 16

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 16
---
 set forth therein.”

ADVISORY VOTE ONLY

This vote is advisory, and therefore not binding on the Company, the Compensation Committee, or the Board of Directors. However, the Compensation Committee will consider the outcome of the vote when considering future executive compensation arrangements. Abstentions and broker non-votes will have no effect on the vote on this proposal.

Executive Compensation

Summary Compensation Table

The table below summarizes all compensation awarded to, earned by, or paid to our Chief Executive Officer and Chief Financial Officer and certain of our other executive officers for 2024 and 2023.

| 14 |

<div align='center'>SUMMARY COMPENSATION TABLE</div>

| Name                                
 and principal position              |     | Year |      |     | Salary 
 ($)    |         |     | Bonus 
 ($)   |         |     | Stock  
 Awards 
 ($)    |         |     | Option 
 Awards 
 ($)    |   |     | Non-Equity                      
 Incentive Plan Compensation ($) |   |     | Nonqualified                   
 Deferred Compensation Earnings 
 ($)                            |   |     | All                
 Other Compensation 
 ($)                |   |     | Total 
 ($)   |         |
| Anatoly Dritschilo M.D., CEO*       |     |      | 2024 |     |        | 274,000 |     |       |       - |     |        |       - |     |        | - |     |                                 | - |     |                                | - |     |                    | - |     |       | 274,000 |
|                                     |     |      | 2023 |     |        | 287,175 |     |       | 112,000 |     |        |       - |     |        | - |     |                                 | - |     |                                | - |     |                    | - |     |       | 399,175 |
| Timothy J. Lorber                   
 CFO**                               |     |      | 2024 |     |        |  97,641 |     |       |       - |     |        | 100,000 |     |        | - |     |                                 | - |     |                                | - |     |                    | - |     |       | 197,641 |
|                                     |     |      | 2023 |     |        |       - |     |       |       - |     |        |       - |     |        | - |     |                                 | - |